Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

Key finding

Method / model

Relevance

Jastreboff, A.M., et al. (2023). Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine, 389(6), 514-526.